| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenues | $45K-70.2% | $152K+20.5% | $126K-14.8% | $148K-25.1% | $197K-15.8% | $234K |
| Salaries and wages | $2.7M-0.9% | $2.8M+7.7% | $2.6M-4.6% | $2.7M-1.9% | $2.7M-6.0% | $2.9M |
| Professional fees | $931K+55.0% | $601K+8.1% | $556K+77.1% | $314K+6.8% | $294K-0.5% | $295K |
| Insurance | $333K-0.1% | $333K+6.8% | $312K-1.3% | $316K-1.8% | $322K-8.4% | $351K |
| Outsource service fees | $736K+5.3% | $699K-0.1% | $700K+14.7% | $610K+67.2% | $365K-18.9% | $450K |
| Data maintenance | $211K+130.7% | $91K-54.7% | $202K+10.6% | $182K-10.9% | $205K+10.7% | $185K |
| General and administrative | $767K+5.6% | $726K+17.7% | $617K-12.6% | $706K+7.2% | $658K-5.4% | $696K |
| Total expenses | $5.7M+9.6% | $5.2M+5.3% | $5.0M-2.5% | $5.1M+3.9% | $4.9M-6.4% | $5.2M |
| Income from operations | $1.0M+17.4% | $853K+25.7% | $679K+1.9% | $666K+29.0% | $516K-37.0% | $820K |
| Other income (Note 14) | $422K | $0 | — | — | — | — |
| Interest income | $474K+14.2% | $415K+1.1% | $410K+1407.2% | $27K | $0 | — |
| Interest expense | -$2K+57.2% | -$4K | $0 | — | — | — |
| Total other income, net | $894K+117.4% | $411K+0.3% | $410K+1407.2% | $27K-96.0% | $680K | $0 |
| Income before taxes | $1.9M+49.9% | $1.3M+16.1% | $1.1M+57.0% | $693K-42.0% | $1.2M+45.8% | $820K |
| Income tax provision | $507K+33.4% | $380K+18.6% | $321K+59.9% | $200K-0.3% | $201K-25.7% | $271K |
| Net income | $1.4M+57.0% | $884K+15.1% | $768K+55.8% | $493K-50.5% | $995K+81.1% | $550K |
| Net Income per share amount (in Dollars per share) | $0.11+57.1% | $0.07+16.7% | $0.06+50.0% | $0.04-50.0% | $0.08+100.0% | $0.04 |
| Weighted average shares outstanding, basic (in Shares) | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M |
| Weighted average shares outstanding, diluted (in Shares) | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M+0.0% | 12.8M |
| HCO | ||||||
| MPN | ||||||
| Medical Bill Review | ||||||
| Utilization Review | ||||||
| Medical Case Management | ||||||
| Other | ||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.